173 related articles for article (PubMed ID: 34044044)
21. Surface proteome mining for identification of potential vaccine candidates against Campylobacter jejuni: an in silico approach.
Mehla K; Ramana J
Funct Integr Genomics; 2017 Jan; 17(1):27-37. PubMed ID: 27778110
[TBL] [Abstract][Full Text] [Related]
22. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
Wu M; Li M; Yue Y; Xu W
Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
[TBL] [Abstract][Full Text] [Related]
23. Excavating the surface-associated and secretory proteome of Mycobacterium leprae for identifying vaccines and diagnostic markers relevant immunodominant epitopes.
Rana A; Thakur S; Bhardwaj N; Kumar D; Akhter Y
Pathog Dis; 2016 Dec; 74(9):. PubMed ID: 27856491
[TBL] [Abstract][Full Text] [Related]
24. Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes.
McMurry J; Sbai H; Gennaro ML; Carter EJ; Martin W; De Groot AS
Tuberculosis (Edinb); 2005; 85(1-2):95-105. PubMed ID: 15687033
[TBL] [Abstract][Full Text] [Related]
25. Designing an efficient multi-epitope vaccine against Campylobacter jejuni using immunoinformatics and reverse vaccinology approach.
Gupta N; Kumar A
Microb Pathog; 2020 Oct; 147():104398. PubMed ID: 32771659
[TBL] [Abstract][Full Text] [Related]
26. Proteome-wide B and T cell epitope repertoires in outer membrane proteins of Mycobacterium avium subsp. paratuberculosis have vaccine and diagnostic relevance: a holistic approach.
Rana A; Rub A; Akhter Y
J Mol Recognit; 2015 Aug; 28(8):506-20. PubMed ID: 25727233
[TBL] [Abstract][Full Text] [Related]
27. Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum.
Pritam M; Singh G; Swaroop S; Singh AK; Singh SP
BMC Bioinformatics; 2019 Feb; 19(Suppl 13):468. PubMed ID: 30717656
[TBL] [Abstract][Full Text] [Related]
28. [Identification and evaluation of T cell epitopes of Rv0585c from
Wang XX; Chen X; Li YQ; Xiao TY; Jiang Y; Li MC; Liu HC; Wan KL
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):665-669. PubMed ID: 28651408
[No Abstract] [Full Text] [Related]
29. In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis.
Martinez-Olivares CE; Hernández-Pando R; Mixcoha E
PLoS One; 2023; 18(4):e0284264. PubMed ID: 37079575
[TBL] [Abstract][Full Text] [Related]
30. Immuno-informatics Analysis to Identify Novel Vaccine Candidates and Design of a Multi-Epitope Based Vaccine Candidate Against
Kar PP; Srivastava A
Front Immunol; 2018; 9():2213. PubMed ID: 30374343
[TBL] [Abstract][Full Text] [Related]
31. In silico predicted mycobacterial epitope elicits in vitro T-cell responses.
Khan MK; Zaman S; Chakraborty S; Chakravorty R; Alam MM; Bhuiyan TR; Rahman MJ; Fernández C; Qadri F; Seraj ZI
Mol Immunol; 2014 Sep; 61(1):16-22. PubMed ID: 24853589
[TBL] [Abstract][Full Text] [Related]
32. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
[TBL] [Abstract][Full Text] [Related]
33. In-silico identification of subunit vaccine candidates against lung cancer-associated oncogenic viruses.
Lathwal A; Kumar R; Raghava GPS
Comput Biol Med; 2021 Mar; 130():104215. PubMed ID: 33465550
[TBL] [Abstract][Full Text] [Related]
34. An immunoinformatics approach to define T cell epitopes from polyketide and non-ribosomal peptide synthesis proteins of Mycobacterium tuberculosis as potential vaccine candidates.
Dhivya S; Baskar V; Kumar SR; Sathishkumar R
J Mol Recognit; 2018 Feb; 31(2):. PubMed ID: 29143375
[TBL] [Abstract][Full Text] [Related]
35. A multiepitopic theoretical fusion construct based on in-silico epitope screening of known vaccine candidates for protection against wide range of enterobacterial pathogens.
Kumar A; Harjai K; Chhibber S
Hum Immunol; 2019 Jul; 80(7):493-502. PubMed ID: 30769032
[TBL] [Abstract][Full Text] [Related]
36. Prediction and analyses of HLA-II restricted Mycobacterium tuberculosis CD4
Jia Z; Gong W; Liang Y; Wu X; Zhao W
Biotechnol Appl Biochem; 2022 Jun; 69(3):1002-1014. PubMed ID: 33886144
[TBL] [Abstract][Full Text] [Related]
37. In silico identification of potential antigenic proteins and promiscuous CTL epitopes in Mycobacterium tuberculosis.
Sundaramurthi JC; Brindha S; Shobitha SR; Swathi A; Ramanandan P; Hanna LE
Infect Genet Evol; 2012 Aug; 12(6):1312-8. PubMed ID: 22484107
[TBL] [Abstract][Full Text] [Related]
38. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
Nain Z; Karim MM; Sen MK; Adhikari UK
Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
[TBL] [Abstract][Full Text] [Related]
39. A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis.
Dhanda SK; Vir P; Singla D; Gupta S; Kumar S; Raghava GP
PLoS One; 2016; 11(4):e0153771. PubMed ID: 27096425
[TBL] [Abstract][Full Text] [Related]
40. Strategies to enhance immunogenicity of cDNA vaccine encoded antigens by modulation of antigen processing.
Platteel ACM; Marit de Groot A; Keller C; Andersen P; Ovaa H; Kloetzel PM; Mishto M; Sijts AJAM
Vaccine; 2016 Sep; 34(42):5132-5140. PubMed ID: 27593157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
